Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

Xixi Lin(Children's Hospital of Zhejiang University), Yicheng Xie(Children's Hospital of Zhejiang University)
Frontiers in Pharmacology
September 11, 2019
Cited by 17


Related Papers